🔬
Foundation Sciences · Genetics
Lysosomal Storage Disorders
Lysosomal storage disorders are inherited deficiencies of lysosomal enzymes leading to substrate accumulation; many are autosomal recessive, some X-linked (e.g. Fabry, Hunter).
📌 Learning Objectives
- Describe the underlying mechanism of Lysosomal Storage Disorders.
- Identify the key clinical features and complications of Lysosomal Storage Disorders.
- Outline the appropriate investigations and management of Lysosomal Storage Disorders.
- Discuss the implications for patients and families of Lysosomal Storage Disorders.
📋 Overview
Examples include Tay–Sachs (HEXA), Gaucher (GBA), Niemann–Pick (SMPD1/NPC1), Fabry (GLA) and Hunter syndrome (IDS).
🔬 Basic Science
Examples include Tay–Sachs (HEXA), Gaucher (GBA), Niemann–Pick (SMPD1/NPC1), Fabry (GLA) and Hunter syndrome (IDS).
🏥 Clinical Relevance
Substrate reduction therapy and gene therapy are emerging options.
🧪 Investigations
Investigation depends on clinical context: relevant blood tests, imaging, and specific genetic or histopathological tests as appropriate. Refer to specialist services where indicated.
💊 Management
Management is condition-specific and typically multidisciplinary, combining medical therapy, surgical intervention where appropriate, supportive care, and family/genetic counselling.
Revision Resources – expand the sections below for high-yield notes, exam pearls, key facts and further reading.
MLA High-Yield Notes & Quick Revision ⌄
Common SBA themes: recognising the underlying mechanism, identifying classic clinical features, and choosing the first-line investigation or management step. Watch for inheritance pattern and characteristic associations.
lysosomal
tay-sachs
gaucher
fabry
hunter
- Tay–Sachs disease is caused by hexosaminidase A deficiency (HEXA gene).
- Gaucher disease (GBA deficiency) is the commonest lysosomal storage disease.
- Fabry and Hunter syndromes are X-linked recessive.
- Enzyme replacement therapy is effective in several lysosomal storage disorders.
- Cherry-red macular spot is seen in Tay–Sachs and Niemann–Pick disease.
Exam Pearls ⌄
⭐ High Yield
Tay–Sachs disease is caused by hexosaminidase A deficiency (HEXA gene).
Gaucher disease (GBA deficiency) is the commonest lysosomal storage disease.
Fabry and Hunter syndromes are X-linked recessive.
Enzyme replacement therapy is effective in several lysosomal storage disorders.
Cherry-red macular spot is seen in Tay–Sachs and Niemann–Pick disease.
💡 Clinical Pearl
Lysosomal: Substrate reduction therapy and gene therapy are emerging options.
⚠️ Exam Tip — Common Mistakes
Confusing the mechanism of Lysosomal Storage Disorders with related conditions.
Missing classic clinical features of Lysosomal Storage Disorders in SBA stems.
Failing to consider Lysosomal Storage Disorders in the differential diagnosis.
Key Facts ⌄
Tay–Sachs disease is caused by hexosaminidase A deficiency (HEXA gene).
Gaucher disease (GBA deficiency) is the commonest lysosomal storage disease.
Fabry and Hunter syndromes are X-linked recessive.
Enzyme replacement therapy is effective in several lysosomal storage disorders.
Cherry-red macular spot is seen in Tay–Sachs and Niemann–Pick disease.
Related Topics ⌄
References ⌄
- GMC MLA Content Map
- NICE Clinical Knowledge Summaries
- BMJ Best Practice
Further Resources
Medical Portfolio & Career Development
Build a professional portfolio website for applications, audits, teaching, research and career progression.
CVtoWebsite.com →